KOLKATA: Following the successful treatment of three cancer patients using CAR-T cell therapy, a private hospital in Kolkata is now introducing 'Made .
In a promising development in the area of cancer treatment, NexCAR19, India s first indigenously developed CAR-T cell therapy is now available for commercial use. It can be given to cancer patients, especially those who are suffering from blood cancer, including leukaemia and lymphomas
Developed by ImmunoAct, IIT Bombay and Tata Memorial Hospital, the therapy has been administered to 15 patients in India. Three of them have successfully achieved cancer remission. Dr Gupta, the first commercial patient to be declared free of cancer, speaks of his experience exclusively to The Indian Express